NSD-788 is a monoamine reuptake inhibitor, which NeuroSearch has evaluated in Phase I studies, demonstrating that NSD-788 has a good safety profile. Further, a Proof of Mechanism study to elucidate the compounds biological mechanism of action has shown that NSD-788 has a uniquely balanced effect on the brain neurotransmitter systems.
NeuroSearch is evaluating the possibility for continued clinical development of NSD-788 in treatment resistant depression.
